Penicillin-binding proteins 1, 2 and 3 in Staphylococcus aureus were found to possess common properties.
All have very strong affinities for both benzylpenicillin and imipenem (N-formimidoylthienamycin), and all have an activity which releases bound imipenem, but not bound benzylpenicillin. Lower molecular weight penicillin-binding protein 4, which has a rather weak affinity for benzylpenicillin and also weak penicillinase activity showed an extraordinarily high affinity for imipenem but no antibiotic-releasing activity.
Four major penicillin-binding proteins (PBPs), PBP-1 to 4, have been isolated from Staphylococcus aureus'). They presumably function in the biosynthesis of peptidoglycan during the process of cellduplication and to be the killing site of (9-lactams in this bacterium. However, no evidence for these assumptions has yet been provided.** Among the four PBPs, the importance of PBP-3 has been suggested by the isolation of a mutant that is more resistant to methicillin and contains PBP-3 with an altered affinity for this i3-lactam2) . The defect of PBP-1 has been reported not to be lethal for the cell'.'). On the other hand, there has been the observation that alteration of all the three higher molecular weight proteins, PBPs-1, 2 and 3, occurred simultaneously with a mutation to methicillin resistance". Probably, these three proteins have similar functions and the lack of one of them may be compensated for by the other. PBP-4, the smallest among the staphylococcal PBPs, has been reported previously to have DD-alanine carboxypeptidase and penicillinase activities".
A defect in PBP-4 was also shown not to be lethal for the cell, but it caused formation of a thinner than normal cell wall4, 7).
We previously studied affinities of PBPs in Escherichia coli and Pseudomonas aeruginosa for imipenem (N-formimidoylthienamycin)8.9) and benzylpenicillin10). In this communication we report similarities among the three higher molecular weight PBPs-1, 2 and 3 of S. aureus, in binding imipenern and benzylpenicillin, and in possessing the property to release imipenem, but not benzylpenicillin.
Affinity and resistance of PBP-4 for imipenem is also reported. ** In Escherichia coli, higer molecular weight PBPs-lA, 1B, 3 and probably also PBP-2 possess two enzymatic activities of peptidoglycan synthesis, i.e., peptidoglycan transglycosylase activity which extends the glycan chain, and N-lactam sensitive transpeptidase activity which crosslinks it9,17~29). These PBPs are supposed to have functions specific for the process of cellular duplication13). On the other hand, in S. aureus major peptidoglycan transglycosylase activity is in fractions different from PBPs and these PBPs possibly have transpeptidase activities only12). Bacterial Strains and Preparation of Membranes S. aureus strain SAK13211), derived from strain Copenhagen, and strain FDA 209P were used in the experiments in this report. Both strains possess PBPs-1 to 4 but strain SAK132 sometimes showed an additional PBP band (PBP-3') between PBPs 3 and 4 on sodium dodecyl sulfate/polyacrylamide gel electrophoresis. Membrane fractions of S. aureus strains were prepared by grinding the log phase cells with alumina followed by differential centrifugation as described previously12) .
Assay of Penicillin-binding Activity of PBPs and Binding Affinity of Imipenem
Assay of PBP by binding of [14C]benzylpenicillin at a low concentration (3 µh1) of [14C]benzylpenicillin, and separation on sodium dodecyl sulfate/polyacrylamide gel electrophoresis was as described for E. coli13), except that the step of Sarkosyl treatment for precipitation of the outer membrane was omitted9).
Binding of imipenem was measured by the competition assay, because no radiolabeled compound was available. In this method, membranes were incubated with the unlabeled antibiotic at various concentrations for an appropriate time The results shown in Table 1 indicate that S. aureus PBPs-l, 2 and 3 (measured together) have OF ANTIBIOTICS VOL. XXXVII NO. 9 Membranes (particulate membrane enzymes) were obtained from S. aureus strain SAK132 by grinding with alumina followed by extraction with 0.01 m sodium phosphate buffer, pH 7.0, differential centrifugation between 5,000 (10 minutes) and 100,000 x g (30 minutes), washing once with the same buffer solution, and suspending in 0.05 m sodium phosphate buffer, pH 7.0 (22.8 mg protein/ ml). The binding experiment was carried out with 228 pig membranes (as protein) and 3 ym [14C]-benzylpenicillin in a total volume of 30°C15) The radioactivity bound to the proteins was measured by cutting the corresponding portions of the dried gel and counting in a liquid scintillation counter using toluene-PPO-POPOP system. Numbers indicate S. aureus PBPs. very strong binding affinities for both imipenem and benzylpenicillin. The binding affinity of imipenem for PBP-4 was very high; its 50% saturation concentration was as low as about 0.01 ,ug/ml. This low saturation concentration of imipenem may probably be due to the resistance of imipenem to penicillinase activity of PBP-410)
The results reflect the susceptibility of strains of S. aureus to both antibiotics. The minimum inhibitory concentrations of imipenem and benzylpenicillin, determined by an agar dilution method as described previously8), were 0.013 and 0.025 jig/ml against strain FDA 209P, and <0.013 and 0.013 pug/ml against strain SAK132, respectively. Fig. 1 ) was incubated for 10 minutes at various temperatures as indicated. Then, 100 plm [14C]benzylpenicillin was added and the binding experiment was carried out for 10 minutes at 30°C. The radioactivity bound to the proteins was measured as described in the legend to Fig. 1 . Numbers indicate S. aureus PBPs. Table 1 After incubation for 10 minutes at 30°C, a 10 fold excess amount of [14C]benzylpenicillin was added to the reaction mixture and the mixture was further incubated at 30°C for times indicated. Detection and determination of the radioactivity in the PBPs were described in the legend to Fig. 1 . Ordinate shows incorporation of [14C]benzylpenicillin in of the incorporation without prebinding of the PBPs with imipenem.
